SINGULAR HEALTH GROUP LTD — Capital/Financing Update 2021

May 26, 2021

==> picture [589 x 86] intentionally omitted <==

Singular Health Group Ltd: SHG

ASX Announcement

27 May 2021

Singular Health launches ‘Scan to Surgery[TM] ’ initiative into $US4.48B medical software & 3D printing market[1]

• Strong support from Singular Health Group (SHG) shareholders enabling acquisition of Virtual Surgical Planning (“VSP”) and investment into Australian Additive Engineering Pty Ltd (“AAE”) (“Transactions”).

• Singular Health is well positioned to become a leading player in the ‘Scan to Surgery’ market. Scan to Surgery[TM] is a disruptive technology and process that revolutionises the planning and execution of surgical procedures, reducing cost and improving patient outcomes.

• Scan to Surgery[TM] addresses a $4.48B opportunity[1] combining medical visualisation software with additive manufacturing, a unique set of technologies and innovations that are transforming healthcare around the world.

27 May 2021 – Singular Health Group Ltd (ASX: SHG) (“Singular Health”, or “the Company”) is pleased to announce that, following the General Meeting conducted on 11 May 2021 where it received overwhelming shareholder support to proceed, the Company has now completed the acquisition of Virtual Surgical Planning (“VSP”) and its investment into Australian Additive Engineering Pty Ltd (“AAE”) (“Transactions”).

Completion of the Transactions included payment to VR Surgical Pty Ltd of $250,000 in cash and the issue of 568,482 fully paid ordinary shares (“Shares”) for the value of $250,000 ($0.4397 per share), which is subject to a voluntary 12-month escrow, and payment of $300,000 to AAE for 25% of the issued capital of that entity.

The strategic acquisition of VSP and investment into AAE accelerates Singular Health’s Scan to Surgery[TM] initiative, bringing the Company closer to its strategic goal of near-term commercialisation of an end-to-end personalised surgical planning platform for the spinal and maxillofacial surgical sectors.

1. Pages 44 & 48 of Singular Health Prospectus dated 9[th] December 2020 (lodged with ASX 12[th] February 2021)

==> picture [596 x 88] intentionally omitted <==

==> picture [154 x 43] intentionally omitted <==

==> picture [435 x 181] intentionally omitted <==

Figure 1: Singular Health's 'Scan to Surgery' Initiative

Thomas Hanly, Singular Health’s Chief Executive Officer, said:

“Following our due diligence and the successful EGM, we are excited to kickstart our Scan to Surgery[TM] initiative with this software acquisition and investment into an Australian-owned and operated medical-grade 3D printing facility.

Scan to Surgery[TM] will enable medical practitioners to visualise radiological images using our proprietary Volumetric Rendering Platform, deploy our Artificial Intelligence models to segment relevant anatomy and use the integrated Virtual Surgical Planning software to manipulate this anatomy and design patient specific medical implants and guides that will be 3D printed at the AAE facility and delivered for surgical use.

All this in one piece of software.”

Please refer to previous ASX announcements on 22 March and 6 April 2021 for further details with respect to the Transactions.

Authorised for release by the Board of Directors of the Company.

Ends.

For further information contact:

Investors	Media	Corporate
James Hill+61 413 825 646jhill@singular.health	Jane Morgan+61 405 555 618jm@janemorganmanagement.com.au	Steven WoodCompany Secretarysw@grangeconsulting.com.au

About Singular Health:

Founded in 2017, Singular Health is a medical technology company that has developed and commercialised the proprietary Volumetric Rendering Platform (“VRP”) for the 3D & VR visualisation of anatomy using standard radiological imagery.

Singular Health is committed to developing technologies that provides patients and practitioners alike with access to personalised, enhanced medical data to inform better health decisions and is currently developing and deploying software products that are built upon the proprietary VRP on a global scale through a direct-to-consumer Software-as-a-Service (“SaaS”) model.

==> picture [586 x 30] intentionally omitted <==

ASX: SHG | www.singular.health

2